Delivery Order SPE2DR25D3110-SPE2DR26F8ED4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Kerendia 10 mg tablets in a 30-count package with a ceiling value of $14,581.71 under firm fixed pricing. This non-set-aside delivery order, due for completion by December 2, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Kerendia 20 mg tablets (30-count units) with a ceiling value of $27,471.06. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on June 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $6,857.16, was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on October 27, 2025, with a ceiling value of $1,466.44 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply contract with DLA. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a contract ceiling value of $59,930.82. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $2,212.01 delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count package) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,658.96 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a $46,258.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Kerendia 10 mg tablets (30-count units). The contract, designated as a non-set-aside competitive award, is scheduled for completion by December 5, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,210.89 delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count supply) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child award, this delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,312.01 to AmerisourceBergen Drug Corp for supply of Kerendia 10 mg tablets (90-unit quantity) on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- SPE2DR25D3110Indefinite Delivery Contract
- SPE2DR25D3110-SPE2DR26F8ED4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $1,038.89. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by December 11, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC provides a comprehensive supply mechanism for pharmaceutical products and medical supplies supporting military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to supply diverse therapeutic products across multiple domains, positioning the company as a critical vendor within the Defense Logistics Agency's medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/9/25 |